# SMART ONE (NCT04939246)

> Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: inoperable primary or metastatic carcinoma

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04939246
- Phase: NA
- Status: COMPLETED
- Sponsor: Baptist Health South Florida
- Conditions: Metastatic Carcinoma
- Interventions: Stereotactic ablative body radiation therapy
- Enrollment: 30
- Primary outcome: Number of Participants With SABR Successfully Delivered in One Fraction
- Primary outcome: Number of Patients Demonstrating Tolerability

## Indexed commentary on SMART ONE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 9 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=smart-one-nct04939246

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04939246", "email": "<work email>"}; the inbox owner confirms by the emailed link.